Article
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Breast cancer research and treatment - 1 Jul 2018
Singh Jaya, Thota Nishita, Singh Suhasini, Padhi Shila, Mohan Puja, Deshwal Shivani, Sur Soumit, Ghosh Mithua, Agarwal Amit, Sarin Ramesh, Ahmed Rosina, Almel Sachin, Chakraborti Basumita, Raina Vinod, DadiReddy Praveen K, Smruti B K, Rajappa Senthil, Dodagoudar Chandragouda, Aggarwal Shyam, Singhal Manish, Joshi Ashish, Kumar Rajeev, Kumar Ajai, Mishra Deepak K, Arora Neeraj, Karaba Aarati, Sankaran Satish, Katragadda Shanmukh, Ghosh Arunabha, Veeramachaneni Vamsi, Hariharan Ramesh, Mannan Ashraf U
Abstract excerpt
PURPOSE: Breast and/or ovarian cancers are among the most common cancers in women across the world. In the Indian population, the healthcare burden of breast and/or ovarian cancers has been steadily rising, thus stressing the need for early detection, surveillance, and disease management measures. However, the burden attributable to inherited mutations is not well characterized. METHODS: We sequenced 1010...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
